RxDoctor Payments Data

Alessandro Iannaccone, MD

Ophthalmology · Chapel Hill, NCNPI 1306802434

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $33,067 of the $44,757 with a category attached, or 73.9%. Biogen accounts for 67.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $41,220 and has fallen 99.6% since, to $147 in 2023. Among ophthalmology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$44,757in general payments, 2019–2025

Across 28 payments — averaging $1598.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$30K
  • Rhythm Pharmaceuticals, Inc.$11K
  • Janssen Global Services, LLC$3K
  • Notal Vision, Inc.$128
  • Mallinckrodt Hospital Products Inc.$120
  • AbbVie$103
  • plus $242 from 5 others
$187,761in research payments, 2019–2025

Across 55 payments — averaging $3413.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$188K

What the payments were for

  • Consulting fees$33,06774%
  • Speaking & faculty fees$10,17823%
  • Travel & lodging$4991%
  • Food & beverage$1,0132%

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,757 in reported general payments places this provider in the 95th percentile of 588 ophthalmology providers in North Carolina.

See all ophthalmology providers in North Carolina

Medicare billing

Part B allowed, 2024
$3,877
Medicare patients
16
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →